| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3M | +30.5% | +453.0% |
| Cost of Revenue | $814K | +27.8% | +166.0% |
| Gross Profit | $458K | +35.5% | +702.6% |
| R&D Expense | $897K | -18.5% | -47.3% |
| SG&A Expense | $1.2M | -3.2% | +21.8% |
| Operating Income | -$2.2M | +21.2% | +38.8% |
| Interest Expense | $4K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.9M | +48.9% | +788.9% |
| Accounts Receivable | $1.2M | +87.2% | +716.4% |
| Inventory | $1.2M | +80.1% | +67.8% |
| Current Assets | $16.6M | +51.2% | +481.6% |
| Total Assets | $17.8M | +44.6% | +351.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.0M | — | — |
| Capital Expenditures | $43K | — | — |
| Investing Cash Flow | -$43K | — | — |
| Financing Cash Flow | $21.6M | — | — |
| Free Cash Flow | -$10.1M | — | — |
| -96.0% |
| — |
| Net Income | -$2.1M | +24.2% | +38.1% |
| EPS (Basic) | -$1.31 | -1537.5% | -162.0% |
| EPS (Diluted) | -$1.31 | -1537.5% | -162.0% |
| $3.4M |
| +24.7% |
| -3.4% |
| Total Liabilities | $4.1M | +15.4% | +16.9% |
| Stockholders' Equity | $13.7M | +56.4% | +3062.7% |